Well, if a strain takes longer to mature, you can assume it costs more (worker attention, electricity, nutrients over that extended flower period). Unfortunately, $14 a gram is probably way over what the costs were to the company plus modest profit - unless they're running a very inefficient operation, which judging by some companies projections/evaluations, some are.
I've noticed a lot of companies, business and investors that seem to have more money than brains. The market really just needs to be legalized, allowing patient's to grow their own as needed and also allow business development in this sector (for a whole host of economic, legal and research reasons). It's extremely irrational to keep prohibition going.